We are live on ! Find out more
KTC

Kistler-Tiffany Companies Portfolio holdings

AUM $616M
1-Year Est. Return 16.74%
This Fund
S&P 500
This Quarter Est. Return
+2.96%
1 Year Est. Return
+16.74%
3 Year Est. Return
+52%
5 Year Est. Return
+77.66%
10 Year Est. Return
+209.93%
AUM
$263M
AUM Growth
+$21.2M
Cap. Flow
+$14.5M
Cap. Flow %
5.51%
Top 10 Hldgs %
50.86%
Holding
604
New
28
Increased
145
Reduced
84
Closed
25

Top Buys

Rank Stock Value
1
MLAB icon
Mesa Laboratories
MLAB
+$6.54M
2
VV icon
Vanguard Morningstar Large-Cap ETF
VV
+$4.83M
3
SDY icon
State Street SPDR S&P Dividend ETF
SDY
+$1.05M
4
IJH icon
iShares Core S&P Mid-Cap ETF
IJH
+$973K
5
SCHM icon
Schwab US Mid-Cap ETF
SCHM
+$826K

Top Sells

Rank Stock Value
1
WST icon
West Pharmaceutical
WST
+$2.88M
2
EXC icon
Exelon
EXC
+$317K
3
VYM icon
Vanguard High Dividend Yield ETF
VYM
+$313K
4
VZ icon
Verizon
VZ
+$279K
5
RTX icon
RTX Corp
RTX
+$272K

Sector Composition

Rank Sector Weight
1 Healthcare 9.99%
2 Technology 8.32%
3 Consumer Staples 4.58%
4 Communication Services 4.11%
5 Financials 3.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WPM icon
401
Wheaton Precious Metals
WPM
$61.3B
$15K 0.01%
629
+5
+0.8% +$111
AZN icon
402
AstraZeneca
AZN
$246B
$14K 0.01%
167
– –
BNS icon
403
Scotiabank
BNS
$110B
$14K 0.01%
260
+1
+0.4% +$53
CARG icon
404
CarGurus
CARG
$3.29B
$14K 0.01%
400
– –
CHTR icon
405
Charter Communications
CHTR
$17.9B
$14K 0.01%
35
– –
KKR icon
406
KKR & Co
KKR
$99.5B
$14K 0.01%
540
– –
MET icon
407
MetLife
MET
$61.4B
$14K 0.01%
290
+190
+190% +$8.93K
AXSM icon
408
Axsome Therapeutics
AXSM
$11.2B
$13K ﹤0.01%
+500
New +$10K
LULU icon
409
lululemon athletica
LULU
$13.7B
$13K ﹤0.01%
+70
New +$12.2K
MCK icon
410
McKesson
MCK
$102B
$13K ﹤0.01%
100
– –
MFIC icon
411
MidCap Financial Investment
MFIC
$795M
$13K ﹤0.01%
840
– –
PJT icon
412
PJT Partners
PJT
$4.36B
$13K ﹤0.01%
321
– –
SNY icon
413
Sanofi
SNY
$105B
$13K ﹤0.01%
300
– –
TEVA icon
414
Teva Pharmaceuticals
TEVA
$42.8B
$13K ﹤0.01%
1,450
– –
TRUP icon
415
Trupanion
TRUP
$1.33B
$13K ﹤0.01%
354
– –
TLND
416
DELISTED
Talend S.A. American Depositary Shares
TLND
$13K ﹤0.01%
331
– –
UN
417
DELISTED
Unilever NV New York Registry Shares
UN
$13K ﹤0.01%
219
– –
CCEP icon
418
Coca-Cola Europacific Partners
CCEP
$47.3B
$12K ﹤0.01%
209
– –
FIVN icon
419
FIVE9
FIVN
$2.33B
$12K ﹤0.01%
239
– –
GEN icon
420
Gen Digital
GEN
$17.1B
$12K ﹤0.01%
572
-240
-30% -$5.16K
NRC icon
421
NRC Health Common Stock
NRC
$456M
$12K ﹤0.01%
202
– –
PFS icon
422
Provident Financial Services
PFS
$3.24B
$12K ﹤0.01%
505
+5
+1% +$127
REGN icon
423
Regeneron Pharmaceuticals
REGN
$82.2B
$12K ﹤0.01%
39
– –
SOXX icon
424
iShares Semiconductor ETF
SOXX
$46.2B
$12K ﹤0.01%
180
– –
VKTX icon
425
Viking Therapeutics
VKTX
$3.97B
$12K ﹤0.01%
1,500
– –
15 16
17
18 19

Similar funds

FANJ
Financial Architects (New Jersey) Marlton, New Jersey $663M AUM 15.53% 1-Year Est. Return
NWM
NEIRG Wealth Management North Andover, Massachusetts $542M AUM 10.92% 1-Year Est. Return
KC
KCL Capital New York $714M AUM 77.46% 1-Year Est. Return
EWM
Endurance Wealth Management Providence, Rhode Island $731M AUM 18.41% 1-Year Est. Return
SAM
Sabadell Asset Management Sant Cugat Del Valles, Spain $482M AUM 27.83% 1-Year Est. Return
TWI
Thomas White International Chicago, Illinois $480M AUM 11.77% 1-Year Est. Return
TF
TimeScale Financial Danvers, Massachusetts $463M AUM 12.48% 1-Year Est. Return
ECI
EFG Capital International Miami, Florida $432M AUM

Kistler-Tiffany Companies's Q2 2019 Portfolio in Review

As of Q2 2019, Kistler-Tiffany Companies held 604 positions worth $263M, up 8.8% from $242M the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Kistler-Tiffany Companies deployed $14.5M of net new capital in Q2 2019, opening 28 new positions and adding to 145 existing holdings. Its largest new stake was Dow Inc: 6,430 shares worth $317K.

By sector, the portfolio is most concentrated in Healthcare at 10% of assets, down from 12% a quarter earlier, followed by Technology and Consumer Staples.

On the sell side, the largest reduction was West Pharmaceutical, an estimated $2.88M trimmed.

  • Kistler-Tiffany Companies's largest Q2 2019 buy was Dow Inc: 6,430 shares worth $317K.
  • Kistler-Tiffany Companies added most to Mesa Laboratories in Q2 2019, an estimated $6.54M increase.
  • Kistler-Tiffany Companies's biggest Q2 2019 reduction was West Pharmaceutical, cutting an estimated $2.88M.
  • Kistler-Tiffany Companies fully exited Blackstone in Q2 2019, selling an estimated $251K.
  • Kistler-Tiffany Companies's ten largest holdings make up 51% of its $263M portfolio in Q2 2019.
  • Kistler-Tiffany Companies opened 28 new positions and closed 25 in Q2 2019.
  • Kistler-Tiffany Companies's portfolio value rose 8.8% quarter-over-quarter to $263M.

Based on Kistler-Tiffany Companies's 13F filing for Q2 2019, filed 22 Jul 2019.